Naturalistic exploratory study of the associations of substance use on ADHD outcomes and function
- PMID: 33980212
- PMCID: PMC8117494
- DOI: 10.1186/s12888-021-03263-6
Naturalistic exploratory study of the associations of substance use on ADHD outcomes and function
Abstract
Background: Although Attention Deficit Hyperactivity Disorder (ADHD) is associated with an increased risk of substance use disorder (SUD), existing literature on how SUD interacts with ADHD outcomes is limited. This study investigates whether SUD among individuals with ADHD is associated with worse ADHD outcomes and prognosis, and the association between overall functioning and SUD. In addition, we seek to understand whether heavy cannabis use is a better predictor of poorer outcomes compared to SUD status alone.
Method: We conducted a retrospective analysis on 50 ADHD patient charts, which were allocated based on SUD status. Subgroup analysis was performed on the total sample population, with allocation based on heavy cannabis use. Mann-Whitney and Chi-Square tests were used for both the primary and subgroup analyses.
Results: SUD status highly correlated with more ADHD-related cognitive impairments and poorer functional outcomes at the time of diagnosis. ADHD patients with comorbid ADHD-SUD scored significantly lower (p = < 0.0001) on objective cognitive testing (Integrated Auditory and Visual Continuous Performance Test (IVA/CPT)) than ADHD patients without SUD. The correlation with poorer ADHD outcomes was more pronounced when groups were allocated based on heavy cannabis use status; in addition to significantly lower IVA/CPT scores (p = 0.0011), heavy cannabis use was associated with more severe fine motor hyperactivity and self-reported hyperactivity/impulsivity scores (p = 0.0088 and 0.0172, respectively).
Conclusion: Future research is needed to determine how substance abuse can be a barrier to improved ADHD outcomes, and the effect cannabis and other substances have on cognitive function and pharmacotherapy of ADHD.
Keywords: Attention-deficit/hyperactivity disorder; Cognition; Psychosocial functioning; Substance abuse.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures



Similar articles
-
The Utility of the CPT in the Diagnosis of ADHD in Individuals with Substance Abuse: A Systematic Review.Eur Addict Res. 2020;26(4-5):283-294. doi: 10.1159/000508041. Epub 2020 Jun 12. Eur Addict Res. 2020. PMID: 32535592
-
Differential Diagnosis in Patients with Substance Use Disorder and/or Attention-Deficit/Hyperactivity Disorder Using Continuous Performance Test.Eur Addict Res. 2020;26(3):151-162. doi: 10.1159/000506334. Epub 2020 Feb 19. Eur Addict Res. 2020. PMID: 32074617
-
The clinical course of comorbid substance use disorder and attention deficit/hyperactivity disorder: protocol and clinical characteristics of the INCAS study.BMC Psychiatry. 2022 Sep 23;22(1):625. doi: 10.1186/s12888-022-04259-6. BMC Psychiatry. 2022. PMID: 36151539 Free PMC article.
-
The International Collaboration on ADHD and Substance Abuse (ICASA): Mission, Results, and Future Activities.Eur Addict Res. 2020;26(4-5):173-178. doi: 10.1159/000508870. Epub 2020 Jun 29. Eur Addict Res. 2020. PMID: 32599579 Free PMC article. Review.
-
Attention deficit/hyperactivity disorders with co-existing substance use disorder is characterized by early antisocial behaviour and poor cognitive skills.BMC Psychiatry. 2013 Dec 13;13:336. doi: 10.1186/1471-244X-13-336. BMC Psychiatry. 2013. PMID: 24330331 Free PMC article.
Cited by
-
Drinking alcohol to cope with hyperactive ADHD? Self-reports vs. continuous performance test in patients with ADHD and/or alcohol use disorder.Front Psychiatry. 2023 Mar 6;14:1112843. doi: 10.3389/fpsyt.2023.1112843. eCollection 2023. Front Psychiatry. 2023. PMID: 36950259 Free PMC article.
-
UK Medical Cannabis Registry: An analysis of clinical outcomes of medicinal cannabis therapy for attention-deficit/hyperactivity disorder.Neuropsychopharmacol Rep. 2023 Dec;43(4):596-606. doi: 10.1002/npr2.12400. Epub 2023 Dec 6. Neuropsychopharmacol Rep. 2023. PMID: 38058251 Free PMC article.
-
The diagnostic effect of integrated visual and auditory continuous performance and event-related potentials in ADHD.Am J Transl Res. 2024 Oct 15;16(10):5248-5267. doi: 10.62347/RPJU2655. eCollection 2024. Am J Transl Res. 2024. PMID: 39544732 Free PMC article.
-
Comorbidity of adult ADHD and substance use disorder in a sample of inpatients bipolar disorder in Iran.BMC Psychiatry. 2022 Jul 19;22(1):480. doi: 10.1186/s12888-022-04124-6. BMC Psychiatry. 2022. PMID: 35854247 Free PMC article.
-
Attention-Deficit Hyperactivity Disorder and Therapeutic Cannabis Use Motives.Psychiatr Clin North Am. 2022 Sep;45(3):503-514. doi: 10.1016/j.psc.2022.05.010. Epub 2022 Aug 1. Psychiatr Clin North Am. 2022. PMID: 36055735 Free PMC article. Review.
References
-
- American Psychiatric Association . Diagnostic and statistical manual of mental disorders. 5. Arlington: American Psychiatric Publishing; 2013.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical